Otsuka touts new IgAN evidence as it seeks full approval for Voyxact

June 4, 2026 06:31 PM EDT R&DPharma Ot­su­ka touts new IgAN ev­i­dence as it seeks full ap­proval for Voyx­act Nicole DeFeudis Senior Reporter Ot­su­ka Phar­ma­ceu­ti­cal re­port­ed new ev­i­dence on Thurs­day that it thinks will help sup­port a full ap­proval for its mon­o­clon­al an­ti­body Voyx­act in a chron­ic au­toim­mune … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER